Storb R, Rudolph R H, Thomas E D
J Clin Invest. 1971 Jun;50(6):1272-5. doi: 10.1172/JCI106605.
Marrow grafts were carried out between 16 canine sibling donor-recipient pairs. The pairs were matched by serological histocompatibility testing and were nonreactive in a one-way mixed leukocyte culture. Recipients were prepared for transplantation by 1500-1580 R of total body irradiation. Donor marrow was infused within 4 hr of irradiation. Recipients were not given immunosuppressive drug therapy after grafting. All 16 recipients showed evidence of prompt and sustained allogeneic marrow engraftment. Six died between 30 and 128 days after grafting with graft-versus-host disease, and three died between days 72 and 230 with pneumonia but no evidence of graft-versus-host disease with the exception of lymphoid atrophy. Seven recipients survived without graft-versus-host disease and are in excellent health between 200 and 684 after grafting. In summary, fatal graft-versus-host disease was observed in a number of canine recipients despite matching with their sibling donor by serological histocompatibility testing and by mixed leukocyte culture in a manner similar to that employed to define human HL-A matched sibling pairs. The graft-versus-host disease in these matched siblings developed more slowly than that observed in mismatched dogs, but the ultimate death of approximately half of the matched recipients emphasizes the need for posttransplantation immunosuppression even in this "compatible" situation.
对16对犬类同胞供体-受体进行了骨髓移植。通过血清学组织相容性检测对这些配对进行匹配,并且在单向混合淋巴细胞培养中无反应。受体通过1500 - 1580拉德的全身照射为移植做准备。在照射后4小时内输注供体骨髓。移植后未给受体进行免疫抑制药物治疗。所有16例受体均显示出迅速且持续的同种异体骨髓植入迹象。6例在移植后30至128天死于移植物抗宿主病,3例在72至230天之间死于肺炎,但除淋巴萎缩外无移植物抗宿主病迹象。7例受体存活且无移植物抗宿主病,移植后200至684天健康状况良好。总之,尽管通过血清学组织相容性检测以及以类似于定义人类HL - A匹配同胞对的方式进行混合淋巴细胞培养使其与同胞供体匹配,但仍有一些犬类受体出现了致命的移植物抗宿主病。这些匹配的同胞中的移植物抗宿主病比在不匹配的犬中观察到的发展得更慢,但大约一半匹配受体最终死亡强调了即使在这种“相容”情况下移植后免疫抑制的必要性。